Chairman and Chief Executive Officer, Gilead Sciences. Mr. O'Day joined Gilead in March 2019 as Chairman of the Board of Directors and Chief Executive Officer. Prior to Gilead, Mr. O'Day served as the Chief Executive Officer of Roche Pharmaceuticals.
Working with Gilead employees around the world to create new possibilities in medicine… · Experience: Gilead Sciences · Education: Columbia University in ...
Daniel O'Day
Toimitusjohtaja, Gilead Sciences
Syntyi: 26. toukokuuta 1964 (ikä 60 vuotta)
Koulutus: Columbian yliopisto (1997) ja Georgetownin yliopisto (1986)
Ihmiset kysyvät myös
How much does Daniel O'Day make?
Who is the new CEO of Gilead?
Who was Daniel O Day's wife?
Who is the Chairman of Gilead Sciences?
Daniel O'Day is a non-executive member of our Board of Directors since 22 October 2019. Mr. O'Day is the Chairman of the Board of Directors and Chief ...
Studies · Georgetown University, Washington DC, Bachelor of Science (Biology) (1986) · Columbia University, New York, MBA (1997) ...
19.3.2024 · Breaking down O'Day's pay package, the CEO's base salary came to $1.74 million last year, a 2.9% increase. O'Day nabbed $11.86 million in stock ...
Daniel O'Day Jr. (March 11, 1870 – May 31, 1916) was one of northwestern Pennsylvania's earliest independent refiners to be brought into John D.
21.2.2024 · Gilead Sciences Chairman and CEO Daniel O'Day has assumed the role of chair of the PhRMA Board of Directors.
21.2.2024 · PhRMA revealed that Gilead Sciences CEO Daniel O'Day has donned the mantle as chair of the board, replacing Novartis chief Vas Narasimhan.
Daniel O'Day is the Chairman and CEO of Gilead, the biopharmaceutical company, which has more than 11,000 employees around the world.
Work History: • Chairman/CEO, Gilead Sciences, 2019 -. Present. • Roche Pharmaceuticals, 1987 - 2018o CEO,. 2016 - 2018o COO/Member of Corporate. Executive.